UNSPSC 51101692: Tivanidazole

This classification denotes an antiprotozoal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7E136TJT00. European Medicines Agency schedules Tivanidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11123MIG. Tivanidazole generally arises in the molecular formula C11H13N5O2S.

UNSPSC 51101692 Tivanidazole is a Commodity code that describes pharmaceutical products procured by state and local health agencies, though recent state and local solicitations tagged under this code show limited direct activity for tivanidazole itself. State and local governments buying under this code are primarily state departments of health and county health departments purchasing pharmaceutical inventory through cooperative purchasing consortia and competitive bidding processes. The Illinois Department of Public Health and Seminole County, Florida represent the issuing bodies in the recent record; these agencies acquire pharmaceuticals to support public health preparedness, emergency response, and community health initiatives. Purchases are structured as multi-year contracts with renewal options and include delivery and storage requirements managed through vendor warehouse operations or direct quarterly distribution to designated health facilities.

Recent activity centers in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for $2,999,999.11 over three years covering Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets via an Invitation for Bid process. Seminole County, Florida released an IFB on June 30, 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2026. Neither recent opportunity directly names tivanidazole; the code shows limited relevant recent procurement activity and may be tagged to state and local opportunities involving different pharmaceutical lines than the code's nominal scope.